RID Named a Judges’ Pick at RESI JPM 2026 Innovator’s Pitch Challenge

Calgary, Alberta. Rapid Infection Diagnostics Inc. (RID) was selected as one of the Top 24 Judges’ Picks at the RESI JPM 2026 Innovator’s Pitch Challenge, one of the most competitive stages for early-stage life science companies during JP Morgan Healthcare Conference week.

RESI JPM brings together more than 90 innovative healthcare and life science companies and connects them directly with active global investors. The Innovator’s Pitch Challenge is a highlight of the event. Each company delivers a six-minute pitch followed by a live Q&A with investor judges who evaluate the science, market opportunity, and readiness to scale.

Dr. Ian Lewis, CEO and Founder of RID, presented the company’s metabolomics-based platform for rapid pathogen identification and antibiotic susceptibility testing. The judges’ recognition places RID among a select group of companies that stood out for scientific strength, commercial clarity, and execution.

“JP Morgan week is intense,” said Dr. Lewis. “You are speaking to investors who see hundreds of companies in a matter of days. Being named a Judges’ Pick tells us that our technology, and the problem we are solving in infectious disease diagnostics, resonates at the highest level.”

Beyond the pitch stage, participating companies also met investors at dedicated exhibition tables and through one on one partnering meetings. Feedback extended well beyond the presentation itself and reflected deeper conversations about differentiation, regulatory strategy, and commercialization plans.

The recognition at RESI JPM builds on RID’s recent momentum, including growing clinical engagement and strategic partnerships as the company advances toward broader adoption of its rapid diagnostic platform.

As RID continues its growth journey, the visibility gained at RESI JPM strengthens its presence within the global life sciences investment community and reinforces the urgency of delivering faster, more actionable infection diagnostics.

Want to see the pitch in action? Watch Dr. Ian Lewis present at RESI JPM 2026.

Next
Next

Rapid Infection Diagnostics Inc. (RID) Honoured with BioAlberta Technology Innovation Award